Argenica Therapeutics LtdASX: AGN

Argenica Receives Ethics Approval To Commence Phase 1 Trial

Sep 7, 2022 at 2:31 AM UTC · Issued by Argenica Therapeutics Ltd

Argenica Therapeutics Ltd has released a press release.

View Attachment